In 1947 was created Charles River Laboratories International, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Wilmington. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 7 participants. Despite the Charles River Laboratories International, startups are often financed by Kurma Partners, Idinvest Partners, Aurinvest. The meaningful sponsors for the fund in investment in the same round are investiere | Verve Capital Partners, Strategic Partners, Norgine Ventures.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the various public portfolio startups of the fund, we may underline PathoQuest
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019.
Related Funds
| Fund Name | Location |
| Divinium Capital | - |
| Genesis Microchip | California, Santa Clara, United States |
| Guangzhou Yuanjian Xinchuang Touzi Guanli Hehuo Qiye (Youxian Hehuo) | China, Guangdong, Guangzhou |
| JOT-Berlin | Berlin, Berlin, Germany |
| oprandi & partner management ag | - |
| Squadron Venture Media | England, London, United Kingdom |
| Tata Communications | India, Maharashtra, Mumbai |
| Weishi Culture Media | Beijing, Beijing, China |
| Yukti Securities | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Ability biologics | $12M | 06 Dec 2023 | Quebec, Quebec, Canada | ||
Vernal Biosciences | $20M | 27 Jun 2023 | Burlington, Vermont, United States | ||
iVexSol | $23M | 26 Jan 2023 | New York, New York, United States | ||
Wheeler Bio | $31M | 04 Oct 2022 | Oklahoma City, Oklahoma, United States | ||
Vernal Biosciences | $21M | 02 Jun 2022 | Burlington, Vermont, United States | ||
Deciphex | $11M | 19 May 2022 | Dublin, County Dublin, Ireland | ||
PathoQuest | $17M | 09 Nov 2021 | Paris, Ile-de-France, France | ||
Bit Bio | $103M | 05 Nov 2021 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Ability biologics | $12M | 06 Dec 2023 | Quebec, Quebec, Canada | ||
Vernal Biosciences | $20M | 27 Jun 2023 | Burlington, Vermont, United States | ||
iVexSol | $23M | 26 Jan 2023 | New York, New York, United States | ||
Wheeler Bio | $31M | 04 Oct 2022 | Oklahoma City, Oklahoma, United States | ||
Vernal Biosciences | $21M | 02 Jun 2022 | Burlington, Vermont, United States | ||
Deciphex | $11M | 19 May 2022 | Dublin, County Dublin, Ireland | ||
PathoQuest | $17M | 09 Nov 2021 | Paris, Ile-de-France, France | ||
Bit Bio | $103M | 05 Nov 2021 | Cambridge, Massachusetts, United States |
